Trial Details

COMPLETED
Basic Information
Clinical ID c1009
Identifier NCT03996369
Trial Title Etrasimod Versus Placebo as Induction Therapy in Moderately to Severely Active Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

YES
Conditions Ulcerative Colitis
Interventions DRUG: Etrasimod|DRUG: Placebo
Participant Information
Sponsor Arena Pharmaceuticals
City Dothan
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement CHILD, ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE3
Time Information
Start Date 2020-09-15
Primary Completion Date 2021-12-07
Completion Date 2021-12-07